Search research articles
Contact Us
Filters
Showing results (61-70 of 95) with videos related to
Page
of 10
Sort By:
Cytotherapy
|
April 25, 2007
Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study
V Lapierre, N Pellegrini, I Bardey, et al.
Hematology and Cell Therapy
|
April 1, 1997
Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems
P Feugier, S Thévenin, M Billot, et al.
Transplantation
|
January 28, 1999
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
D Ducloux, E Pellet, V Fournier, et al.
Transplantation Proceedings
|
September 24, 1998
CD4 lymphocytopenia in long-term renal transplant recipients
D Ducloux, P L Carron, E Racadot, et al.
Bone Marrow Transplantation
|
May 1, 1995
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients
E Racadot, N Milpied, P Bordigoni, et al.
European Cytokine Network
|
September 1, 1994
Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis
S Bresson-Hadni, O Petitjean, B Monnot-Jacquard, et al.
Presse Medicale (Paris, France : 1983)
|
March 31, 1984
[Prevention of graft-versus-host disease. Elimination of T-lymphocytes from bone marrow cells by complement-dependent cytolysis with a combination of pan-T monoclonal antibodies]
P Herve, E Racadot, M Flesch, et al.
Bone Marrow Transplantation
|
January 1, 1991
IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?
P Tiberghien, E Racadot, T Fest, et al.
Bone Marrow Transplantation
|
January 1, 1991
Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody
P Hervé, E Racadot, J Wijdenes, et al.
Nouvelle Revue Francaise D'Hematologie
|
June 1, 1993
Interleukin-1 treatment before allogeneic bone marrow transplantation: pre-clinical studies
P Tiberghien, V Laithier, M Mabed, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 95) with videos related to
Sort By:
Page
of 10
Cytotherapy
|
April 25, 2007
Cord blood volume reduction using an automated system (Sepax) vs. a semi-automated system (Optipress II) and a manual method (hydroxyethyl starch sedimentation) for routine cord blood banking: a comparative study
V Lapierre, N Pellegrini, I Bardey, et al.
Hematology and Cell Therapy
|
April 1, 1997
Comparison of T cell depletion strategies from bone marrow, umbilical cord and peripheral blood using five separation systems
P Feugier, S Thévenin, M Billot, et al.
Transplantation
|
January 28, 1999
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
D Ducloux, E Pellet, V Fournier, et al.
Transplantation Proceedings
|
September 24, 1998
CD4 lymphocytopenia in long-term renal transplant recipients
D Ducloux, P L Carron, E Racadot, et al.
Bone Marrow Transplantation
|
May 1, 1995
Sequential use of three monoclonal antibodies in corticosteroid-resistant acute GVHD: a multicentric pilot study including 15 patients
E Racadot, N Milpied, P Bordigoni, et al.
European Cytokine Network
|
September 1, 1994
Cellular localisations of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha mRNA in a parasitic granulomatous disease of the liver, alveolar echinococcosis
S Bresson-Hadni, O Petitjean, B Monnot-Jacquard, et al.
Presse Medicale (Paris, France : 1983)
|
March 31, 1984
[Prevention of graft-versus-host disease. Elimination of T-lymphocytes from bone marrow cells by complement-dependent cytolysis with a combination of pan-T monoclonal antibodies]
P Herve, E Racadot, M Flesch, et al.
Bone Marrow Transplantation
|
January 1, 1991
IL-2 treatment after autologous bone marrow transplantation in poor prognosis Hodgkin's disease: defective IL-2-induced LAK activity?
P Tiberghien, E Racadot, T Fest, et al.
Bone Marrow Transplantation
|
January 1, 1991
Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody
P Hervé, E Racadot, J Wijdenes, et al.
Nouvelle Revue Francaise D'Hematologie
|
June 1, 1993
Interleukin-1 treatment before allogeneic bone marrow transplantation: pre-clinical studies
P Tiberghien, V Laithier, M Mabed, et al.
Page
of 10